Honoring the Legacy of Dr. Ido Weinberg, MD, MSc, MHA, FSVM (1976–2026)
Overview
Dr. Ido Weinberg, a prominent figure in vascular medicine, passed away on January 22, 2026. His contributions to the field, particularly through mentorship and leadership in the Society for Vascular Medicine, are noted.
Background
Dr. Weinberg's career spanned over 15 years in vascular medicine, where he was recognized for his dedication to education and mentorship. His roles included serving as the Medical Director of VasCore and Program Director for the Vascular Medicine Fellowship at Massachusetts General Hospital. His leadership in the Society for Vascular Medicine advanced the field and supported the development of future vascular medicine professionals.
Data Highlights
No numerical or trial data available in the source material.
Key Findings
Dr. Weinberg served as Past President of the Society for Vascular Medicine from 2023 to 2024.
He was involved in modernizing educational resources for vascular medicine, including the Online Board Review Course.
Dr. Weinberg was a clinical investigator and educator, known for his lectures at major cardiovascular meetings.
He played a role in establishing the SVM’s Michael R Jaff, DO, MSVM, Fellows Leadership Institute.
His leadership contributed to the Society for Vascular Medicine.
Clinical Implications
Dr. Weinberg's commitment to mentorship and education in vascular medicine highlights the importance of leadership in advancing medical training. His innovative approaches to education may serve as a model for future initiatives in the field.
Conclusion
Dr. Ido Weinberg's legacy in vascular medicine is marked by his dedication to mentorship, leadership, and innovation. His contributions will continue to influence the field and inspire future generations of vascular medicine professionals.
by Gaurav Parmar, Herbert D Aronow, Mark A Creager, Andrew Dicks, Michael Jaff, Yogendra Kanthi, Raghu Kolluri, Vladimir Lakhter, Elizabeth V Ratchford, Robert Schainfeld, Sneha Thomas, Mitchell D Weinberg, Esther SH Kim
An interpretable machine-learning model classified angiographic coronary artery disease in patients referred for coronary angiography, but high disease prevalence and unclear inflammatory signals limited clinical interpretation.
Plasma proteomic models of more than 40 cell types were associated with incident Alzheimer's disease, amyotrophic lateral sclerosis, cancer, and mortality across three large cohorts.
